NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B

NYSE issues a pre-market daily advisory direct from the trading floor.

The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

Ashley Mastronardi delivers the pre-market update on August 5th

• The Dow Jones Industrial Average and S&P 500 will look to build off fresh records on hopes of a deal in the Middle East.
  • The Dow surpassed 54,000 for the first time ever.
  • The S&P 500 clinched its first-ever close above 7,700.
• Expedition Therapeutics Founder & CEO Yi Larson will join NYSE Live following her firm's latest funding round.
  • The company says the first patients have been dosed in its Phase 2 clinical trial for EXPD-101, a next-gen treatment for COPD.
• Zeta Global (NYSE: ZETA) CEO David Steinberg will join NYSE Live to deliver the biggest takeaways from the company's Q2 earnings report.
  • The firm says it posted its 20^th straight 'beat-and-raise' quarter and achieved the 'Rule of 64.'

Opening Bell
AB InBev (NYSE: BUD) rings the NYSE Opening Bell

Closing Bell
Blend (NYSE: BLND) celebrates its 5^th anniversary of listing

For market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-update-expedition-therapeutics-secures-115-million-series-b-302843756.html

SOURCE New York Stock Exchange

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/August2026/05/c2982.html